Compare ARK Genomic Revolution ETF (ARKG) vs Honeywell International Inc (HON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Honeywell International Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.89, while Honeywell International Inc trades at $224.03 (market cap $71.74B). The key difference: Honeywell International Inc pays a 4.2% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Honeywell International Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | HON | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $248.04 |
52-Week Low | $23.09 | $188.14 |
Market Cap | — | $71.74B |
Enterprise Value | — | $96.08B |
Dividend Yield | — | 4.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Honeywell International (HON) trades at $226.42, up 1.34% with neutral technical signals. The company maintains strong profitability with 10.89% net margin and 26.41% ROE, though revenue declined slightly to $37.44B in 2025. Recent corporate actions include a 2:1 reverse stock split and dividend payment, while analyst consensus remains bullish with a $402.40 price target. Technical indicators show mixed signals with RSI neutral and ADX suggesting bullish momentum.
HON presents a compelling investment case with strong fundamentals and analyst support, though near-term risks include declining profit margins and increased debt levels. The stock's current valuation at 18.08 P/E appears reasonable given growth prospects in automation and defense sectors, but investors should monitor execution of post-spinoff strategy and macroeconomic headwinds affecting industrial demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →
